Vaishnaw Akshay Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
36
Insider Sells Sum
$84.61M

Insider Activity of Vaishnaw Akshay

According to the SEC Form 4 filings, Vaishnaw Akshay, being in a position of

  1. President of R&D at Scholar Rock Holding Corporation,
    оver the last 12 months, has bought 0 shares, and sold 32684 shares for $1.48M,
    over all time since 2025-05-29, has bought 0 shares, and sold 39434 shares for $1.68M.

Biography of Vaishnaw Akshay

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,479,7922100

Comparison of Insiders on Amount of Buys and Sells

2026-04-16SaleScholar Rock Holding Corporation
SRRK
President of R&D
12,246
0.0106%
$49.57$607,089-2.78%
2026-01-13SaleScholar Rock Holding Corporation
SRRK
President of R&D
20,438
0.0196%
$42.70$872,703+8.89%
2025-05-29SaleScholar Rock Holding Corporation
SRRK
President of R&D
6,750
0.0071%
$29.72$200,612+37.8%
2023-08-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
4,057
0.0033%
$185.85$753,986-8.87%
2023-04-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
2,392
0.0019%
$194.59$465,464-8.12%
2023-02-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
President
38,044
0.0308%
$215.97$8.22M-11.82%
2021-12-23SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
2,879
0.0024%
$190.93$549,698-16.26%
2021-08-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
10,834
0.0091%
$200.00$2.17M-18.91%
2021-06-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
14,708
0.0124%
$175.00$2.57M-3.94%
2021-04-21SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
2,732
0.0023%
$136.95$374,135+23.86%
2021-04-19SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
3,706
0.0032%
$137.67$510,192+23.97%
2020-09-29SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
971
0.0008%
$140.00$135,940+0.27%
2020-06-22SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
970
0.0008%
$151.07$146,536-8.51%
2020-04-20SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
21,971
0.0185%
$140.00$3.08M-3.95%
2020-02-07SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
23,708
0.0209%
$125.00$2.96M+7.8%
2018-03-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
President, R&D
177,108
0.1787%
$143.10$25.34M-34.38%
2017-10-30SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, R&D
67,332
0.0692%
$121.46$8.18M-14.61%
2017-05-23SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, R&D
22,000
0.0161%
$48.17$1.06M+53.06%
2017-05-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
SVP, R&D
43,750
0.0489%
$65.00$2.84M+73.63%
2016-11-30SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, R&D, CMO
58,330
0.0697%
$44.99$2.62M+64.12%
Total: 39
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.